Although previous studies have suggested that LPAR6 served as an oncogene in hepatocellular carcinoma and pancreatic carcinoma, it is rational to consider, from our results, that in breast cancer, LPAR6 acts as an antitumor factor. This evidence concerns the gene LPAR6 and hepatocellular carcinoma.